4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001697616-26-000002
Chief Financial Officer sold 1,797 shares at $26.28 ($47,225)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Dyne Therapeutics, Inc. Filed Acc 0001697616-26-000002
Chief Financial Officer sold 1,797 shares at $26.28 ($47,225)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…